Skip to main content
. Author manuscript; available in PMC: 2014 Apr 4.
Published in final edited form as: J Pharm Pract. 2011 Nov 18;25(2):151–159. doi: 10.1177/0897190011424803

Table 1.

Baseline Demographic Characteristics of the Newly Diagnosed Atrial Fibrillation Patients Across the Different Treatment Groups

Total, % Treatment strategy
P valuea
Rate control, % Rhythm control, % Nonpharmacotherapy, %
N 3094 2068 (66.84) 394 (12.73) 632 (20.43)
Age group
 18–54 590 (19.07) 375 (63.56) 86 (14.58) 129 (21.86) .1456
 55–64 910 (29.41) 550 (60.44) 125 (13.74) 235 (25.82) <.0001
 65–79 1026 (33.16) 700 (68.23) 129 (12.57) 197 (19.20) .4488
 ≥80 568 (18.36) 443 (77.99) 54 (9.51) 71 (12.50) <.0001
Gender
 Female 1245 (40.24) 906 (72.77) 156 (12.53) 183 (14.70) <.0001
 Male 1849 (59.76) 1162 (62.84) 238 (12.87) 449 (24.28) <.0001
Region
 East 572 (18.49) 435 (76.05) 41 (7.17) 96 (16.78) <.0001
 Mid-west 1176 (38.01) 735 (62.50) 158 (13.44) 283 (24.06) .0001
 South 872 (28.18) 587 (67.32) 142 (16.28) 143 (16.40) <.0001
 West 474 (15.32) 311 (65.61) 53 (11.18) 110 (23.21) .1917
Comorbidity
 Stroke 135 (4.36) 101 (74.81) 19 (14.07) 15 (11.11) .0116
 Hypertension 733 (23.69) 507 (69.17) 86 (11.73) 140 (19.10) .0737
 Diabetes 263 (8.50) 171 (65.02) 28 (10.65) 64 (24.33) .2838
 MI 426 (13.77) 270 (63.38) 54 (12.68) 102 (23.94) .2493
 CHF 292 (9.44) 177 (60.62) 33 (11.30) 82 (28.08) .0062

Abbreviations: CHF, congestive heart failure; MI, myocardial infarction.

a

P values from chi-square tests.